Necrolytic migratory erythema in a patient with neuroendocrine carcinoma

Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine.

Saved in:
Bibliographic Details
Main Authors: Gronau, Michaela (Author) , Jäger, Dirk (Author) , Enk, Alexander (Author) , Hassel, Jessica C. (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Internal medicine
Year: 2013, Volume: 52, Issue: 1, Pages: 151-152
ISSN:1349-7235
DOI:10.2169/internalmedicine.52.8499
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2169/internalmedicine.52.8499
Get full text
Author Notes:Michaela Gronau, Dirk Jäger, Alexander H. Enk and Jessica C. Hassel
Description
Summary:Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine.
Item Description:Gesehen am 10.03.2021
Physical Description:Online Resource
ISSN:1349-7235
DOI:10.2169/internalmedicine.52.8499